Eastern europe surgical drapes and gowns market

Eastern Europe Surgical Drapes and Gowns Market, by Product Type (Surgical Drapes (Cardiovascular Drapes, General Procedure Drapes, Orthopedic Drapes, Ophthalmic Drapes, Gynecology, Obstetrics, & Urology Drapes, and Other Surgical Drapes) and Surgical Gowns), by Usage Pattern (Disposable and Reusable), by End User (Hospitals & Clinics and Ambulatory Surgical Centers), and by Country (Croatia, Czech Republic, Hungary, Poland, Romania, Russia, and Rest of Eastern Europe) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Request Free Sample

Nov 2020
CMI4266
181 Pages
Excel & Pdf
Medical Devices

Summary

A surgical gown is classified by the U.S. Food Drug and Administration (FDA) as a Class II medical device that requires 510(k) premarket notification. Surgical gowns can be used for any risk level (Levels 1-4) such as Level 1: Used for minimal risk situations, during basic care, or in a standard medical unit; Level 2: Used in low risk situations such as drawing blood, suturing, or in a pathology lab; Level 3: Used in moderate risk situations, for inserting an intravenous (IV) line, emergency room, or for trauma cases; Level 4: Used in high risk situations such as for pathogen resistance or non- airborne diseases, and infectious diseases.

The Eastern Europe surgical drapes and gowns market size is estimated to be valued at US$ 55.27 million in 2020 and is expected to exhibit a CAGR of 3.8% over the forecast period (2020-2027).

Figure 1. Eastern Europe Surgical Drapes and Gowns Market Value (US$ Mn), 2016-2027

The rising number of hospital acquired infections (HAI) during hospitalization due to exposure of patients to pathogens through different sources such as hospital environment, and other infected patients is one of the key factors that is expected to drive growth of the Eastern Europe surgical drapes and gowns market over the forecast period. For instance, according to the annual epidemiological report for surgical site infections, published by the European Centre for Disease Prevention and Control, in 2016, stated that the rate of surgical site infections (SSIs) after coronary artery bypass graft operations, cholecystectomy operations, caesarean sections, and colon surgery was 3.4%, 1.7%, 1.4%, and 13.2%, respectively.

Furthermore, increasing number of surgical procedures, owing to rising incidence of chronic and infectious diseases and medical emergencies such as cardiac cases and sudden trauma are the major factors contributing to the growth of the Eastern Europe surgical drapes and gowns market. For instance, according to the annual epidemiological report for surgical site infections 2016, published by European Centre for Disease Prevention and Control, the number of surgeries performed in the Hungary was around 9,094 in the year 2016.

Eastern Europe Surgical Drapes and Gowns Market Report Coverage

Report Coverage	Details
Base Year:	2019	Market Size in 2020:	US$ 55.27 Mn
Historical Data for:	2016 to 2019	Forecast Period:	2020 to 2027
Forecast Period 2020 to 2027 CAGR:	3.8%	2027 Value Projection:	US$ 71.7 Mn
Geographies covered:	Europe: Croatia, Czech Republic, Hungary, Poland, Romania, Russia, and Rest of Eastern Europe.
Segments covered:	By Product Type: Surgical Drapes: Cardiovascular Drapes, General Procedure Drapes, Orthopedic Drapes, Ophthalmic Drapes, Gynecology, Obstetrics, & Urology Drapes, Other Surgical Drapes. Surgical Gowns By Usage Pattern: Disposable, Reusable. By End User: Hospitals & Clinics, Ambulatory Surgical Centers.
Companies covered:	Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, Aphena Pharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical, and Sun Pharmaceutical Industries Ltd.
Growth Drivers:	Increasing Number of hospital-acquired infections such as nosocomial infections Increasing number of surgical procedure in Eastern Europe.
Restraints & Challenges:	The availability of limited products due to an increase in the number of product recalls

Eastern Europe Surgical Drapes and Gowns Market – Impact of Coronavirus (Covid-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in over 50.9 million infected individuals worldwide as of November 11, 2020.

Moreover, increasing spread of the novel coronavirus has hampered growth of the Eastern Europe surgical drapes and gowns market. For instance, In March 2020, the World Health Organization (WHO) declared COVID-19 as an Eastern Europe pandemic and suggested implementation of strict measures to minimize the spread of this disease. The pandemic slowed down growth of the healthcare sector and led to a disturbance in the supply chain

Figure 2. Eastern Europe Surgical Drapes and Gowns Market Share (%), by Region, 2020

Among countries, Russia is expected to hold dominant position in the Eastern Europe surgical drapes and gowns market during the forecast period, owing to increasing number of surgical procedures in the country. For instance, according to an article published in the National Center for Biotechnology Information (NCBI) February 2017, around 75,378 per-cutaneous coronary intervention (PCI) and around 101,451 stent placements procedures were performed in 175 Russian percutaneous coronary intervention (PCI) Centers.

Key Players

Major players operating in the Eastern Europe surgical drapes and gowns market include 3M, Halyard Health, Inc., Thermo Fisher Scientific Inc, Steril Medical, Molnlycke Healthcare AB, Cardinal Health, Inc, Medica Europe BV, Priontex, Paul Hartmann AG, Guardian Surgical, Alpha Pro Tech, Ltd, Anhui Medpurest Medical Technology Co., Ltd, Lohmann & Rauscher International GmbH & Co. KG, Vygon S.A, Medline Industries, Inc, Garmex Medical Textiles, TIDI Products, LLC, Stryker Corporation, Teleflex Incorporated, Surgeine Healthcare (India) Private Limited, and Amaryllis Healthcare Private Limited.

Table of Content

*Browse 31 market data tables and 26 figures on "Eastern Europe Drapes and Gown Market– Country-wise forecast to 2027”.

N/A

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2020-2027)?

The Eastern Europe surgical drapes and gowns market size is estimated to be valued at US$ 55.27 million in 2020 and is expected to exhibit a CAGR of 3.8% between 2020 and 2027.

What are the major drivers for the Eastern Europe surgical drapes and gowns market growth?

The increasing number of hospital-acquired infections such as nosocomial infections and increasing number of surgical procedures in Eastern Europe are the major factors that are expected to drive the market growth.

Which is the leading product type segment in the Eastern Europe surgical drapes and gowns market?

Surgical gowns segment is estimated to account for major market share in the Eastern Europe surgical drapes and gowns market, owing to increasing necessity of surgical gowns in the operating room for facilitating a sterile environment.

Which is the leading usage pattern segment in the Eastern Europe surgical drapes and gowns market?

Disposable segment is estimated to account for major market share in the Eastern Europe surgical drapes and gowns market, owing to increasing number of surgical procedures requiring use of disposable drapes and gowns to maintain a sterile environment.

Which country is estimated to generate the largest market share in 2020 in the Eastern Europe surgical drapes and gowns market?

Russia is estimated to generate largest revenue share in 2020 in the Eastern Europe surgical drapes and gowns market.

What are the key factors hampering growth of the market?

The availability of limited products due to increasing number of product recalls is a key factor that is expected to hamper growth of the market.